These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 31761193)

  • 1. Development of conjugate-by-conjugate structured nanoparticles for oral delivery of docetaxel.
    Ha-Lien Tran P; Wang T; Yang C; Tran TTD; Duan W
    Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110346. PubMed ID: 31761193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trastuzumab decorated TPGS-g-chitosan nanoparticles for targeted breast cancer therapy.
    Kumar Mehata A; Bharti S; Singh P; Viswanadh MK; Kumari L; Agrawal P; Singh S; Koch B; Muthu MS
    Colloids Surf B Biointerfaces; 2019 Jan; 173():366-377. PubMed ID: 30316083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docetaxel-loaded PAMAM-based poly (γ-benzyl-l-glutamate)-b-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles in human breast cancer and human cervical cancer therapy.
    Wang Y; Zuo A; Huang X; Ying Y; Shu X; Chen X; Yang Y; Ma J; Lin G; Wang X; Mei L; Liu G; Zhao Y
    J Microencapsul; 2019 Sep; 36(6):552-565. PubMed ID: 31403342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake.
    Cho HJ; Park JW; Yoon IS; Kim DD
    Int J Nanomedicine; 2014; 9():495-504. PubMed ID: 24531717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-delivery of docetaxel and Poloxamer 235 by PLGA-TPGS nanoparticles for breast cancer treatment.
    Tang X; Liang Y; Feng X; Zhang R; Jin X; Sun L
    Mater Sci Eng C Mater Biol Appl; 2015 Apr; 49():348-355. PubMed ID: 25686959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-Delivery of Docetaxel and Salinomycin to Target Both Breast Cancer Cells and Stem Cells by PLGA/TPGS Nanoparticles.
    Gao J; Liu J; Xie F; Lu Y; Yin C; Shen X
    Int J Nanomedicine; 2019; 14():9199-9216. PubMed ID: 32063706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate-conjugated liposomal docetaxel reverses multidrug resistance in breast cancer cells.
    Li N; Fu T; Fei W; Han T; Gu X; Hou Y; Liu Y; Yang J
    J Pharm Pharmacol; 2019 Aug; 71(8):1243-1254. PubMed ID: 31215039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ionically Cross-Linked Chitosan Nanoparticles for Sustained Delivery of Docetaxel: Fabrication, Post-Formulation and Acute Oral Toxicity Evaluation.
    Mahmood MA; Madni A; Rehman M; Rahim MA; Jabar A
    Int J Nanomedicine; 2019; 14():10035-10046. PubMed ID: 31908458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer.
    Wang Z; Zeng X; Ma Y; Liu J; Tang X; Gao Y; Liu K; Zhang J; Ming P; Huang L; Mei L
    J Biomed Nanotechnol; 2014 Aug; 10(8):1509-19. PubMed ID: 25016651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural Coptidis Rhizoma Nanoparticles Improved the Oral Delivery of Docetaxel.
    Ye D; Ding D; Pan LY; Zhao Q; Chen L; Zheng M; Zhang T; Ma BL
    Int J Nanomedicine; 2024; 19():8417-8436. PubMed ID: 39176130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trastuzumab-conjugated nanoparticles composed of poly(butylene adipate-
    Varshosaz J; Ghassami E; Noorbakhsh A; Minaiyan M; Jahanian-Najafabadi A
    IET Nanobiotechnol; 2019 Oct; 13(8):829-833. PubMed ID: 31625523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galactosylated TPGS Micelles for Docetaxel Targeting to Hepatic Carcinoma: Development, Characterization, and Biodistribution Study.
    Tekchandani P; Kurmi BD; Paliwal R; Paliwal SR
    AAPS PharmSciTech; 2020 Jun; 21(5):174. PubMed ID: 32548786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of poly(ε-caprolactone) chain lengths of poly(ε-caprolactone)-co-d-α-tocopheryl-poly(ethylene glycol) 1000 succinate nanoparticles for enhancement of quercetin delivery to SKBR3 breast cancer cells.
    Suksiriworapong J; Phoca K; Ngamsom S; Sripha K; Moongkarndi P; Junyaprasert VB
    Eur J Pharm Biopharm; 2016 Apr; 101():15-24. PubMed ID: 26802701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity.
    Deng L; Dong H; Dong A; Zhang J
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):107-17. PubMed ID: 26515259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate-Functionalized Thiomeric Nanoparticles for Enhanced Docetaxel Cytotoxicity and Improved Oral Bioavailability.
    Sajjad M; Khan MI; Naveed S; Ijaz S; Qureshi OS; Raza SA; Shahnaz G; Sohail MF
    AAPS PharmSciTech; 2019 Jan; 20(2):81. PubMed ID: 30645705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy.
    Wang Y; Chen L; Tan L; Zhao Q; Luo F; Wei Y; Qian Z
    Biomaterials; 2014 Aug; 35(25):6972-85. PubMed ID: 24836952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery.
    Kulkarni SA; Feng SS
    Pharm Res; 2013 Oct; 30(10):2512-22. PubMed ID: 23314933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic acid-oleylamine and chitosan-oleic acid conjugate-based hybrid nanoparticle delivery via. dissolving microneedles for enhanced treatment efficacy in localized breast cancer.
    Jha A; Kumar M; Goswami P; Manjit M; Bharti K; Koch B; Mishra B
    Biomater Adv; 2024 Jun; 160():213865. PubMed ID: 38643693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery.
    Wu Y; Chu Q; Tan S; Zhuang X; Bao Y; Wu T; Zhang Z
    Int J Nanomedicine; 2015; 10():5219-35. PubMed ID: 26316751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.